Related Experiment Videos

A method for removing interleukin-1- and tumor necrosis factor-inducing substances from bacterial cultures by

R Schindler1, C A Dinarello

  • 1Department of Medicine, Tufts University School of Medicine, Boston, MA.

Insights

Human mononuclear cells (MNC) cytokine production is a sensitive test for microbial products. Ultrafiltration effectively removes endotoxins from bacterial cultures, ensuring parenteral fluid safety with comparable sensitivity to the Limulus amebocyte lysate (LAL) test.

Area of Science:

  • Microbiology
  • Immunology
  • Biotechnology

Background:

  • Cytokine production by human mononuclear cells (MNC) serves as a sensitive indicator for microbial products.
  • Current parenteral fluid safety assessment relies on the Limulus amebocyte lysate (LAL) test for endotoxin detection.

Purpose of the Study:

  • To evaluate the efficacy of ultrafiltration in removing endotoxins from bacterial cultures.
  • To compare the sensitivity of MNC cytokine production assay with the LAL test for endotoxin detection.

Main Methods:

  • Crude bacterial culture supernatants from Escherichia coli were subjected to polysulfone ultrafiltration.
  • Ultrafiltrates were tested for their ability to stimulate human MNC cytokine production (Interleukin-1 and Tumor Necrosis Factor).
  • Radioimmunoassay was used to quantify cytokine levels.

Main Results:

  • Ultrafiltration demonstrated a rejection factor of at least 100,000 for endotoxin-like substances.
  • Endotoxin removal occurred via molecular size exclusion and absorption.
  • MNC cytokine production assay showed comparable sensitivity to the LAL test.

Conclusions:

  • Ultrafiltration is a highly effective method for removing endotoxins from materials used in parenteral fluid production.
  • This study demonstrates a significant safety margin for producing parenteral fluids using ultrafiltration, even with endotoxin-containing materials.

Related Concept Videos